Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases

Genes Chromosomes and Cancer

Volumn 53, Issue 2, 2014, Pages 177-182

  Pilarski, Robert ^a   Cebulla, Colleen M ^b   Massengill, James B ^b   Rai, Karan ^a   Rich, Thereasa ^c   Strong, Louise ^c   Mcgillivray, Barbara ^d   Asrat, Mary Jill ^d   Davidorf, Frederick H ^b   Abdel Rahman, Mohamed H ^a,b,e  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

^e MENOUFIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BAP1 PROTEIN; MELAN A; ONCOPROTEIN; PROTEIN S 100; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER RISK; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS MELANOMA; DISTANT METASTASIS; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LIVER HILUS; MALE; MESOTHELIOMA; MICROSATELLITE MARKER; PHENOTYPE; PRIORITY JOURNAL; SPINDLE CELL; UVEA MELANOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, RENAL CELL; CHOLANGIOCARCINOMA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; KIDNEY NEOPLASMS; LIVER NEOPLASMS; MALE; MELANOMA; MESOTHELIOMA; MIDDLE AGED; MUTATION; NEOPLASTIC SYNDROMES, HEREDITARY; PEDIGREE; PHENOTYPE; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE; UVEAL NEOPLASMS; YOUNG ADULT;

EID: 84890127613     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22129     Document Type: Article

References (17)

1. Abdel-Rahman MH, Pilarski R, Ezzat S, Sexton J, Davidorf FH. 2010. Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma. Fam Cancer 9:431-438.
2. Abdel-Rahman MH, Pilarski R, Cebulla CM, Massengill JB, Christopher BN, Boru G, Hovland P, Davidorf FH. 2011. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J Med Genet 48:856-859.
3. Carbone M, Korb Ferris L, Baumann F, Napolitano A, Lum CA, Flores EG, Gaudino G, Powers A, Bryant-Greenwood P, Krausz T, Hyjek E, Tate R, Friedberg J, Weigel T, Pass HI, Yang H. 2012. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med 10:179.
4. Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G. 2013. BAP1 and cancer. Nat Rev Cancer 13:153-159.
5. Hebsgaard SM, Korning PG, Tolstrup N, Engelbrecht J, Rouze P, Brunak S. 1996. Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. Nucleic Acids Res 24:3439-3452.
6. Hoiom V, Edsgard D, Helgadottir H, Eriksson H, All-Ericsson C, Tuominen R, Ivanova I, Lundeberg J, Emanuelsson O, Hansson J. 2013. Hereditary uveal melanoma: A report of a germline mutation in BAP1. Genes Chromosomes Cancer 52:378-384.
7. Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H. 1990. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. J Clin Pathol 43:213-219.
8. Miller SA, Dykes DD, Polesky HFrn. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
9. Murali R, Wiesner T, Scolyer RA. 2013. Tumours associated with BAP1 mutations. Pathology 45:116-126.
10. Njauw CN, Kim I, Piris A, Gabree M, Taylor M, Lane AM, DeAngelis MM, Gragoudas E, Duncan LM, Tsao H. 2012. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One 7:e35295.
11. Popova T, Hebert L, Jacquemin V, Gad S, Caux-Moncoutier V, Dubois-d'Enghien C, Richaudeau B, Renaudin X, Sellers J, Nicolas A, Sastre-Garau X, Desjardins L, Gyapay G, Raynal V, Sinilnikova OM, Andrieu N, Manie E, de Pauw A, Gesta P, Bonadona V, Maugard CM, Penet C, Avril MF, Barillot E, Cabaret O, Delattre O, Richard S, Caron O, Benfodda M, Hu HH, Soufir N, Bressac-de Paillerets B, Stoppa-Lyonnet D, Stern MH. 2013. Germline BAP1 mutations predispose to renal cell carcinomas. Am J Hum Genet 92:974-980.
12. Reese MG, Eeckman FH, Kulp D, Haussler D. 1997. Improved splice site detection in Genie. J Comput Biol 4:311-323.
13. Ribeiro C, Campelos S, Moura CS, Machado JC, Justino A, Parente B. 2013. Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation. Ann Oncol 24:2147-2150.
14. Ruitenbeek T, Gouw AS, Poppema S. 1994. Immunocytology of body cavity fluids. MOC-31, a monoclonal antibody discriminating between mesothelial and epithelial cells. Arch Pathol Lab Med 118:265-269.
15. Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, Tanji M, Gaudino G, Yang H, Carbone M. 2011. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 43:1022-1025.
16. Tong GX, Devaraj K, Hamele-Bena D, Yu WM, Turk A, Chen X, Wright JD, Greenebaum E. 2010. Pax8: a marker for carcinoma of Mullerian origin in serous effusions. Diagn Cytopathol 39:567-574.
17. Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, Windpassinger C, Wackernagel W, Loy S, Wolf I, Viale A, Lash AE, Pirun M, Socci ND, Rutten A, Palmedo G, Abramson D, Offit K, Ott A, Becker JC, Cerroni L, Kutzner H, Bastian BC, Speicher MR. 2011. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 43:1018-1021.